Where is Pillcheck located?

Pillcheck is headquartered in Vaughan, Canada.

How many employees does Pillcheck have?

As of Mar 31, 2026, the latest employee count at Pillcheck is 12.

Where does Pillcheck rank among its competitors?

Pillcheck ranks 127th amongst 523 active competitors, of which 65 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sebia, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Pillcheck?

Pillcheck's top competitors include Qiagen, Enzo and Parse Biosciences. Among them, Sebia secured the most recent funding round in May, 2026.

Pillcheck - 2026 Company Profile, Team, Funding & Competitors

Pillcheck is a funded company based in Vaughan (Canada), founded in 2013 by Ruslan Dorfman. It operates as a Provider of DNA testing platform to identify medication response of users. The company has 523 active competitors, including 65 funded and 73 that have exited. Its top competitors include companies like Qiagen, Enzo and Parse Biosciences.

Company Details

Pillcheck provides DNA testing platform to identify medication response of users. It provides medication response solutions that help users to remind about their medicines. It covers multiple health disorders such as mental health, heart disease, digestive system, and pain management, nausea management, and others. It provides solutions for employers, health plans, plan members, and many more.

Website: pillcheck.ca
Social
Email ID: *****@pillcheck.ca
Phone Number: +1 **********
Part Of

Key Metrics

Founded Year

2013

Location

Vaughan, Canada

Stage

Funding Raised

Investors

Ontario Centre of Innovation

Ranked

127^th among 523 active competitors

Employee Count

12 as on Mar 31, 2026

Similar Companies

Qiagen & 360 more

View Pillcheck's full profile

Pillcheck is a funded company. Pillcheck has 1 institutional investor.

View details of Pillcheck's funding rounds and investors

The founders of Pillcheck is Ruslan Dorfman.

Here are the details of Pillcheck's key team members:

Ruslan Dorfman: Founder of Pillcheck and founder of 1 other company.

View details of Pillcheck's Founder profiles and Board Members

Pillcheck's employee count trend

Pillcheck has 12 employees as of Mar 26. Here is Pillcheck's employee count trend over the years:

Uncover Pillcheck's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pillcheck include Qiagen, Enzo and Parse Biosciences. Here is the list of Top 10 competitors of Pillcheck, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Qiagen 1984, Venlo (Netherlands), Acquired	Provider of products and reagents for molecular diagnostic assays	-	Life Sciences Partners, Harmonic & 6 others	65/100
2nd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	Battery Ventures	65/100
3rd	Parse Biosciences 2018, Seattle (United States), Series C	Developer of RNA-sequencing solution-based transcriptome kit to analyze health data	$100M	Marshall Wace, Janus Henderson Investors & 8 others	64/100
4th	House Rx 2005, San Francisco (United States), Series B	Provider of a technology-based medication solution for patients and caregivers	$100M	First Round Capital, New Enterprise Associates ... & 9 others	63/100
5th	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
6th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
7th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	58/100
8th	RareCyte 2009, Seattle (United States), Series C	Developer of technologies for the analysis of rare and single cells in the blood	$114M	Arboretum Ventures, Health Quest Capital ... & 11 others	57/100
9th	Neogen 1982, Lansing (United States), Acquired	Solutions for food and animal safety, diagnostics, and genomics	$700K	Innovative Ventures, NISA	56/100
10th	Sebia 1967, Evry Courcouronnes (France), Acquired	Developer of electrophoresis-based in vitro diagnostics products	-	Warburg Pincus, HarbourVest Partners & 5 others	56/100
127th	Pillcheck 2013, Vaughan (Canada), Funding Raised	Provider of DNA testing platform to identify medication response of users	-	Ontario Centre of Innovation	31/100